Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial

NCT00030771 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00030771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00030771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial
Lead sponsor
Swiss Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
April 4, 2001
Completion date
September 15, 2023
Enrollment
232 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer